North America Tissue Sectioning Market Analysis, Size, and Share by 2028

The North America tissue sectioning market is expected to reach US$ 352.32 million by 2028 from US$ 222.37 million in 2021. It is estimated to grow at a CAGR of 6.8% from 2021 to 2028.

The increasing prevalence of chronic diseases and the rising adoption of personalized medicines are supporting the regional market. However, the lack of skilled professionals is expected to restrict the market growth during the forecast period.

Under the Ministry of Health and Family Welfare (MoHFW) and the Government of India, the NHM backed all states to provide essential diagnostics at their public health installations free of cost in India. Taking this initiative to global position, the WHO released the original edition of the Essential Diagnostics List (EDL) in May 2018. Fastening on the significance of diagnosis, the WHO stated the testing affects the majority of medical opinions. Appropriate diagnostic tests can inform evidence-based treatment and accountable use of medicines, performing in the overall bettered allocation of resources and better health outcomes.

With a remarkable rise in the aging population, several chronic ailments cases are showing an increase, leading to the necessity toward prevention and cure from a disorder, and, hence, the medical decision. Tissue sectioning (including necropsies, surgical or necropsy samples) is a core part of histopathological examinations, on which the physicians can blindly rely for the result accuracy. The superficial tissue sections may not represent the whole necropsy, which leads to repeated requests for deeper sections to enhance sensitivity and diagnostic delicacy. The data mentioned above and factors are performing in an increase in the number of remedial establishments. For illustration, pathology laboratories and clinics have increased the appropriation of tissue sectioning. These developments and rapid adoption are shifting the focus of pathologists and researchers toward exploring other approaches. Also, this massive contribution to ineffective treatments with the aid of histopathological examination is a significant factor in the growth of the tissue sectioning market. Due to an increasing number of infected patients, healthcare professionals and leading organizations in the US raised the demand for histopathological tests for severe Covid-19 incidents, encouraging the research and healthcare sector to focus actively on innovation.

North America is the leading market that has significantly contributed to the growth of the tissue sectioning market before the pandemic. Hence, the overall impact of Covid-19 on North America’s tissue sectioning market is positive. There have been various factors, including increased incidences of Covid-19 positive patients, growth in research, increasing production of vaccines, outcome study of the administered vaccine, and many other factors. For instance, the College of American Pathologists conducted research to report demographic and radiographic features in the lungs of patients infected and deceased with fatal Covid-19. All autopsies were performed at the College of American Pathologists. The study revealed that patients infected with Covid-19 have diffuse alveolar damage and commonly have acute bronchopneumonia and aspiration pneumonia. The cases led to the demand for diagnostic tests in the countries like the US, Canada, and Mexico. Thus, the tissue sectioning market in North America is positively impacted by Covid-19.

 North America Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Mn)

NORTH AMERICA TISSUE SECTIONING MARKET SEGMENTATION

By Product

• Instruments
  • Rotary Microtome
  • Ultramicrotome
  • Cryostat
  • Sliding Microtome
  • Others
• Accessories and Consumables
• Services

By Technology

• Automatic
• Semi-Automatic
• Manual

By Application

• Diagnosis
• Research

By End User

• Hospitals
• Clinics
• Diagnostic Laboratories
• Digital Path Labs
• Others

By Country

• U.S
• Canada
• Mexico

Company Profiles

• THERMO FISHER SCIENTIFIC, INC.
• Leica Biosystems Nussloch GmbH (Danaher)
• Diapath S.p.A
• MEDITE Medical GmbH
• Abcam Plc

North America Tissue Sectioning Report Scope